Ignite Creation Date:
2024-05-06 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03685331
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-06
First Post:
2018-09-18
Brief Title:
HOPE Olaparib Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated HR HER2-metastatic Breast Cancer
Sponsor:
Organization:
Abramson Cancer Center at Penn Medicine